Key result
Frailty-inflammation phenotype linked to ~2.7-fold higher 1-year MACE risk vs. lower-risk cluster.
Why the study?
Prognosis among AMI patients shows substantial heterogeneity, necessitating precise identification of high-risk phenotypes to improve long-term outcomes.
Does a machine learning-derived 'frailty-inflammation' phenotype predict 1-year MACE in patients with acute myocardial infarction?
Cohort (n=1,139)
No
Does a machine learning-derived 'frailty-inflammation' phenotype predict 1-year MACE in patients with acute myocardial infarction?
Hazard Ratio: 2.726 (95% CI 1.986–3.743)
p-value: p=<0.001
Integrating physical function and behavioral patterns with clinical characteristics via machine learning identifies a 'frailty-inflammation' phenotype that strongly predicts adverse outcomes in patients with AMI.
May aid AMI risk stratification by frailty-inflammation phenotype; hypothesis-generating and requires prospective validation before practice change.
Background Prognosis among patients with acute myocardial infarction (AMI) shows substantial heterogeneity, making precise identification of high-risk phenotypes essential for improving long-term outcomes. Machine learning techniques were used to identify such phenotypes by integrating multidimensional data and to examine their association with major adverse cardiovascular events (MACE). Methods A total of 1,139 patients with AMI were enrolled from the First Affiliated Hospital of Harbin Medical University between March 2023 and June 2024. Multidimensional data, including clinical features, metabolic characteristics, and behavioral patterns, were collected. Phenotyping was performed using a hierarchical clustering algorithm. Associations between derived phenotypes and 1-year MACE were evaluated using Kaplan–Meier survival analysis and multivariable Cox regression models. Shapley Additive Explanations (SHAP) values derived from an XGBoost model were used to quantify the contributions of individual variables to cluster assignment. Results Hierarchical clustering identified two clinical phenotypes with differing pathophysiological characteristics. Cluster 2 ( n = 243, 21.3%) exhibited a high-risk “frailty–inflammation” phenotype, characterized by impaired activities of daily living, elevated risk of falls and pressure ulcers, increased high-sensitivity C-reactive protein (hs-CRP) levels, and poor health behaviors. Compared with Cluster 1, patients in Cluster 2 showed a higher hazard of 1-year MACE (unadjusted HR = 4.17; 95% CI: 3.237–5.371; P < 0.001) and a markedly increased risk of all-cause mortality (HR = 12.162; 95% CI: 7.445–19.868; P < 0.001). After adjustment using the minimal sufficient confounding model (M3, incorporating 17 prespecified confounders), Cluster 2 membership remained significantly associated with an increased risk of 1-year MACE (adjusted HR = 2.726; 95% CI 1.986–3.743; P < 0.001) and all-cause mortality (adjusted HR = 4.35; 95% CI 2.393–7.905; P < 0.001). In multivariable Cox regression analysis, Cluster 2 membership was identified as an independent predictor for MACE. Conclusions Integration of multidimensional data using machine learning identifies a high-risk “frailty–inflammation” phenotype in patients with AMI. This phenotype offers a comprehensive biological–functional–behavioral framework for risk stratification and may support early and precise clinical interventions to reduce long-term adverse outcomes. However, despite its potential clinical value, the current evidence is insufficient to support direct translation into routine clinical practice until independent cohort validation is performed. Future multi-center studies are warranted to confirm the robustness and generalizability of this approach, and to prospectively evaluate whether phenotype-guided intervention strategies can improve long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cohort in Acute myocardial infarction (AMI) (n=1,139). High-risk "frailty-inflammation" phenotype (Cluster 2) vs. Cluster 1 (lower-risk phenotype) was evaluated on 1-year major adverse cardiovascular events (MACE) (adjusted HR 2.726, 95% CI 1.986-3.743, p=<0.001). The high-risk frailty-inflammation phenotype was independently associated with an increased risk of 1-year MACE compared to the lower-risk cluster (adjusted HR 2.726).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: